GSA Capital Partners »

Kymera Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $468k 12k 40.19
2023-12-31 $575k 23k 25.47
2023-09-30 $710k 51k 13.90
2023-06-30 $487k 21k 22.99
2022-12-31 $332k 13k 24.96
2022-09-30 $261k 12k 21.74
2022-06-30 $589k 30k 19.68
2022-03-31 $254k 6.0k 42.32
2021-12-31 $1.8M 28k 63.49